Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Cappellini

Showing results (31-40 of 39) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 39 results.
Scientific Data|April 11, 2024
CT Cadaveric dataset for Radiomics features stability assessment in lumbar vertebraeRiccardo Levi, Maximiliano Mollura, Giovanni Savini, et al.
Scientific Reports|August 20, 2024
A reference framework for standardization and harmonization of CT radiomics features on cadaveric sampleRiccardo Levi, Maximiliano Mollura, Giovanni Savini, et al.
Leukemia|September 28, 2017
Therapeutic targeting of CK2 in acute and chronic leukemiasF Buontempo, J A McCubrey, E Orsini, et al.
Leukemia|January 12, 2007
Multidrug resistance-associated protein 1 expression is under the control of the phosphoinositide 3 kinase/Akt signal transduction network in human acute myelogenous leukemia blastsP L Tazzari, A Cappellini, F Ricci, et al.
Leukemia|October 12, 2007
Proapoptotic activity and chemosensitizing effect of the novel Akt inhibitor perifosine in acute myelogenous leukemia cellsV Papa, P L Tazzari, F Chiarini, et al.
Journal of Inherited Metabolic Disease|April 10, 2009
Neuropathological study of skeletal muscle, heart, liver, and brain in a neonatal form of glycogen storage disease type IV associated with a new mutation in GBE1 geneC Lamperti, S Salani, S Lucchiari, et al.
Leukemia|March 5, 2010
Erucylphosphohomocholine, the first intravenously applicable alkylphosphocholine, is cytotoxic to acute myelogenous leukemia cells through JNK- and PP2A-dependent mechanismsA M Martelli, V Papa, P L Tazzari, et al.
Leukemia|November 21, 2013
Cytotoxic activity of the casein kinase 2 inhibitor CX-4945 against T-cell acute lymphoblastic leukemia: targeting the unfolded protein response signalingF Buontempo, E Orsini, L R Martins, et al.
Neuro-Oncology|April 2, 2025
AI differentiates radionecrosis from true progression in brain metastasis upon stereotactic radiosurgery: analysis of 124 histologically assessed lesionsGaia Ressa, Riccardo Levi, Giovanni Savini, et al.
Pageof 4

Showing results (31-40 of 39) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 39 results.
Scientific Data|April 11, 2024
CT Cadaveric dataset for Radiomics features stability assessment in lumbar vertebraeRiccardo Levi, Maximiliano Mollura, Giovanni Savini, et al.
Scientific Reports|August 20, 2024
A reference framework for standardization and harmonization of CT radiomics features on cadaveric sampleRiccardo Levi, Maximiliano Mollura, Giovanni Savini, et al.
Leukemia|September 28, 2017
Therapeutic targeting of CK2 in acute and chronic leukemiasF Buontempo, J A McCubrey, E Orsini, et al.
Leukemia|January 12, 2007
Multidrug resistance-associated protein 1 expression is under the control of the phosphoinositide 3 kinase/Akt signal transduction network in human acute myelogenous leukemia blastsP L Tazzari, A Cappellini, F Ricci, et al.
Leukemia|October 12, 2007
Proapoptotic activity and chemosensitizing effect of the novel Akt inhibitor perifosine in acute myelogenous leukemia cellsV Papa, P L Tazzari, F Chiarini, et al.
Journal of Inherited Metabolic Disease|April 10, 2009
Neuropathological study of skeletal muscle, heart, liver, and brain in a neonatal form of glycogen storage disease type IV associated with a new mutation in GBE1 geneC Lamperti, S Salani, S Lucchiari, et al.
Leukemia|March 5, 2010
Erucylphosphohomocholine, the first intravenously applicable alkylphosphocholine, is cytotoxic to acute myelogenous leukemia cells through JNK- and PP2A-dependent mechanismsA M Martelli, V Papa, P L Tazzari, et al.
Leukemia|November 21, 2013
Cytotoxic activity of the casein kinase 2 inhibitor CX-4945 against T-cell acute lymphoblastic leukemia: targeting the unfolded protein response signalingF Buontempo, E Orsini, L R Martins, et al.
Neuro-Oncology|April 2, 2025
AI differentiates radionecrosis from true progression in brain metastasis upon stereotactic radiosurgery: analysis of 124 histologically assessed lesionsGaia Ressa, Riccardo Levi, Giovanni Savini, et al.
Pageof 4